Cathy C. XieFollowEli Lilly (United States)1 paperOpenAlexPapersAmerican Journal of Preventive CardiologyHuman trial·2 hStudy design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertensionGLP-1 receptor agonists
American Journal of Preventive CardiologyHuman trial·2 hStudy design, rationale, and baseline characteristics of ATTAIN-HYPERTENSION, a phase 3 trial of the oral GLP-1 receptor agonist orforglipron for hypertensionGLP-1 receptor agonists